The Lancet Oncology

Top Research Topics at Lancet Oncology?

The scientific interests tackled in the journal are Internal medicine, Oncology, MEDLINE, Cancer and Surgery. The journal features Internal medicine research that overlaps with concepts in Text mining. Oncology research featured in Lancet Oncology incorporates concerns from various other topics such as Radiation therapy, Carcinoma, Prostate cancer and Colorectal cancer.

It focused on MEDLINE research but expanded to cover Intensive care medicine. It focuses on Cancer research which is adjacent to topics in Family medicine. The journal addresses concerns in Surgery which are intertwined with other disciplines, such as Gastroenterology, Adverse effect and Hazard ratio.

• Internal medicine (42.81%)
• Oncology (32.46%)
• MEDLINE (19.16%)

What are the most cited papers published in the journal?

• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (5011 citations)
• Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. (3957 citations)
• Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. (3881 citations)

Research areas of the most cited articles at Lancet Oncology:

The most cited articles are organized to address concerns in the fields of Internal medicine, Surgery, Oncology, Clinical endpoint and Cancer. The published papers connects research in Internal medicine with the related topics of Gastroenterology. Breast cancer, Prostate cancer, Colorectal cancer and Phases of clinical research are some topics wherein Oncology research discussed in the journal publications has an impact.

What topics the last edition of the journal is best known for?

• Cancer
• Internal medicine
• Disease

The previous edition focused in particular on these issues:

Lancet Oncology aims to foster the development of research in Internal medicine, MEDLINE, Oncology, Cancer and Text mining. The journal connects research in Internal medicine with the related topic of Gastroenterology. While work presented in Lancet Oncology provided substantial information on MEDLINE, it also covered topics in Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Radiation therapy, Radiology and 2019-20 coronavirus outbreak.

Pembrolizumab, Immunotherapy, Breast cancer and Colorectal cancer are some topics wherein Oncology research discussed in Lancet Oncology have an impact. Topics in Cancer were tackled in line with various other fields like Family medicine and Intensive care medicine. The study of Clinical endpoint encompasses disciplines such as Neutropenia, as well as fields such as Phases of clinical research, all of which overlap with one another.

The most cited articles from the last journal are:

• Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. (104 citations)
• First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial (93 citations)
• Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. (92 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Lancet Oncology (based on the number of publications) are:

• Talha Khan Burki (322 papers) published 12 papers at the last edition, 2 more than at the previous edition,
• Kathryn Senior (99 papers) absent at the last edition,
• Adrian Burton (95 papers) absent at the last edition,
• Elizabeth Gourd (90 papers) published 5 papers at the last edition, 7 less than at the previous edition,
• Manjulika Das (89 papers) published 15 papers at the last edition, 14 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Lancet Oncology (based on the number of publications) are:

• Harvard University (418 papers) published 36 papers at the last edition, 3 less than at the previous edition,
• University of Texas MD Anderson Cancer Center (336 papers) published 23 papers at the last edition, 14 less than at the previous edition,
• Memorial Sloan Kettering Cancer Center (296 papers) published 28 papers at the last edition, 6 less than at the previous edition,
• Institut Gustave Roussy (224 papers) published 24 papers at the last edition the same number as at the previous edition,
• The Royal Marsden NHS Foundation Trust (210 papers) published 13 papers at the last edition, 6 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 24.47% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 36.45% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.72% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.64% of all publications and 40.19% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

The Importance of Oncology Research

Oncology research holds immense significance in the medical field and is the driving force behind new and advanced treatments aiding in cancer recovery. The primary goal is to understand the biology of cancer, its risk factors and to develop new strategies for prevention, early detection, prognostication and treatment. The articles published in Lancet Oncology encompass a diverse range of sub-disciplines including nuclear medicine, radiation oncology, surgical oncology, and medical oncology. The research incorporated relates to various forms of cancer and contributes to advances in understanding their mechanisms, diagnosis, and management. An essential area where such research is proving instrumental is regional oncology concerns, including access to quality cancer care and treatments. Some of the most underserved and underprivileged areas confront more considerable challenges in terms of accessibility, treatment, and education. Rural healthcare facilities, for instance, may sometimes lack specialized oncology programs that are readily available in urban regions. An excellent example further demonstrating the real-world implication is seen in the case of Kansas, where an increasing number of licensed practical nurses (LPNs) are venturing into oncology assisting in cancer care. These LPNs often opt for specialized lpn programs in kansas online aiding in catering to the region's rising oncology needs. In conclusion, oncology research is crucial to progressing cancer treatment and raising the quality bar of medical care, helping change lives and transform communities, especially in underprivileged sectors. It forms the backbone of numerous medical advancements leading to newer and more effective ways of combating the exhausting battle against cancer, thus significantly contributing to global health.